Search results

Crohn's Disease Forum

Help Support Crohn's Disease Forum:

  1. Crohn2357

    The IBD Therapeutic Pipeline is Primed to Produce

    Review Digestion . 2020 Jun 22;1-14. doi: 10.1159/000507782. Online ahead of print. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More Benjamin Misselwitz 1, Pascal Juillerat 2, Michael Christian Sulz 3, Britta Siegmund 4, Stephan Brand 3, Swiss IBDnet...
  2. Crohn2357

    Pediatric Crohn's Disease and COVID-19 Treated with Infliximab

    kiny, read these: https://off-guardian.org/2020/03/24/12-experts-questioning-the-coronavirus-panic https://off-guardian.org/2020/03/28/10-more-experts-criticising-the-coronavirus-panic/ https://off-guardian.org/2020/04/17/8-more-experts-questioning-the-coronavirus-panic/
  3. Crohn2357

    Systematic review: gastrointestinal infection and incident inflammatory bowel disease

    Aliment Pharmacol Ther. 2020 Jun;51(12):1222-1232. doi: 10.1111/apt.15770. 2020 May 5. Systematic review: gastrointestinal infection and incident inflammatory bowel disease Jordan E Axelrad 1 , Ken H Cadwell 1 2 , Jean-Frederic Colombel 3 , Shailja C Shah 4 PMID: 32372471 PMCID...
  4. Crohn2357

    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis

    Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis Joana Torres ∗ Francesca Petralia ∗ Takahiro Sato Mark S. Riddle § Jean-Frederic Colombel § on behalf ofthe Mount Sinai Road to Prevention Group Published: March 09, 2020 DOI...
  5. Crohn2357

    QuBiologics new phase 2 trial recruiting soon

    @Hal Gunn, could you share the adjuvant(s) used in the vaccine?
  6. Crohn2357

    QuBiologics new phase 2 trial recruiting soon

    I just read this: https://www.quibd.com/2019/12/19/qu-biologics-completes-enrollment-in-first-stage-of-phase-2-clinical-trial-in-moderate-to-severe-crohns-disease/ Also this: https://www.quibd.com/phase-2-clinical-trial-trial/
  7. Crohn2357

    QuBiologics new phase 2 trial recruiting soon

    That’s very good to hear, I hope this state of goodness will continue for you. Thanks for sharing.
  8. Crohn2357

    Anti-MAP Therapy Support Group

    A Message from Professor Hermon-Taylor https://www.crohnsmapvaccine.com/a-message-from-professor-hermon-taylor/
  9. Crohn2357

    Newly diagnosed (16 years old) boy

    https://www.igibdscores.it/en/info-rutgeerts.html
  10. Crohn2357

    Newly diagnosed (16 years old) boy

    https://www.gastrojournal.org/article/0016-5085(85)90042-3/pdf
  11. Crohn2357

    Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double

    United European Gastroenterol J. 2015 Jun; 3(3): 294–302. doi: 10.1177/2050640615572176 PMCID: PMC4480538 PMID: 26137304 Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn’s disease: Results from a randomised double-blind placebo-controlled...
  12. Crohn2357

    New vaccine possibility (not MAP)

    kiny, I have a hypothetical question for you. If there was a safe and effective method of eradicating AIEC from Crohn’s patients, never to return, would that cure Crohn’s? Imagine the patients take a pill, it kills all the AIEC in the patients’ body and the AIEC won’t ever come into the body of...
  13. Crohn2357

    New vaccine possibility (not MAP)

    https://link.springer.com/chapter/10.1007%2F7355_2014_52 https://clinicaltrials.gov/ct2/show/NCT02998190 https://clinicaltrials.gov/ct2/show/NCT03709628 https://www.gastrojournal.org/article/S0016-5085(17)33350-4/pdf
  14. Crohn2357

    Anti-MAP Therapy Support Group

    https://humanpara.org/october-2019-update-map-crohns-disease-testing-study/
  15. Crohn2357

    Anti-MAP Therapy Support Group

    Human Paratuberculosis Foundation Quarterly Newsletter October 2019 https://humanpara.org/wp-content/uploads/2019/10/The-MAP-Gap-10-1-19.pdf
  16. Crohn2357

    Remicade anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases

    “The question then arises as to how anti-TNF drugs can be effective against a condition in which the secretion of TNF and other pro-inflammatory cytokines is impaired? The answer is in the timing of the different components of the immune system. The call to arms of the innate immune system is a...
  17. Crohn2357

    Anti-MAP Therapy Support Group

    Antibiotic Add-On Active in Crohn's Disease More evidence for a mycobacterial origin Charles Bankhead,October 31, 2019 SAN ANTONIO -- Treatment with an oral antibiotic combination led to clinically and significantly meaningful improvement in clinical response and remission in patients with...
  18. Crohn2357

    Anti-MAP Therapy Support Group

    King’s College London Thank-You Brochure President and Principal of King’s College London, Professor Edward Byrne, thanks everyone who has supported Crohn’s test research. In the booklet you can also read contributions from Professor Hermon-Taylor, Dr Amy Hermon-Taylor, Dr Gaurav Agrawal, Dr...
Back
Top